News

MY PASSION IS

TO RESTORE YOUR BODY'S

NATURAL HEALING POWER

News

News

News News

SPM research and pain: what two published studies looked at

1:14 am 8 October 2026 0 Comments

Readers who live with ongoing aches or stiff joints often ask about supplements they have seen discussed. One that has come up recently involves specialised pro-resolving mediators, or SPMs.

The science in brief

SPMs are compounds made from omega-3 fatty acids. Researchers study them because of their apparent involvement in resolving inflammation, the stage when the body switches an inflammatory response off.

The two studies cited

In October 2026 Metagenics emailed practitioners about an SPM product sold only through practitioners, which is why it is not named here. The email referred to two papers. The first, by Callan and colleagues in 2020, was an open-label, single-arm study in which adults with chronic pain took an SPM-enriched marine lipid for four weeks. Single-arm means there was no comparison group. The second, the GAUDI study by Moller and colleagues in 2023, was randomised, double-blind and placebo-controlled, in people with symptomatic knee osteoarthritis. Both looked at pain and quality of life measures.

Studies like these are part of a developing field. They cannot tell anyone whether a product will suit them, and supplements can interact with prescribed medicines. Pain also has many causes that need proper assessment.

Our practitioners consider movement, history, other treatments and medicines before suggesting anything. Our clinic group's Healthy Market sells Metagenics products only on that basis.

If you want to discuss whether SPMs are relevant to your situation, ask at your next appointment.

Comments are disabled

News

Search
Recent entries
Categories

News